Bionexo do Brasil S.A.

Based in Brazil, Bionexo do Brasil S. A. offers cloud-based technology solutions that enhance healthcare supply chain management and streamline procurement processes across medical institutions. Bionexo do Brasil S.

A. specializes in healthcare technology, founded in 2000 in São Paulo, Brazil. The company was established by Mauricio Barbosa and Mauricio De Lázzari Barbosa. In October 2023, the firm raised USD 100.

000 mn in a GROWTH round led by Bain Capital, bringing the total funds raised to USD 100. 000 mn. The company has successfully completed 5 deals. Bionexo provides SaaS technology solutions designed specifically for the healthcare sector.

Their platform optimizes supply chain management and revenue cycle processes, facilitating the procurement of medical supplies and improving visibility over billing. Serving over 3,500 healthcare institutions and more than 30,000 suppliers, Bionexo's solutions reduce waste and streamline surgical processes, primarily across Latin America but adaptable for international markets. In 2017, Bionexo reported revenue of USD 18,776,693. 80 and an EBITDA of USD 1,355,339.

The company's revenue model is based on subscriptions from healthcare institutions using its technology for effective supply chain and revenue cycle management. Bionexo plans to leverage the recent investment of BRL 100 million from Bain Capital to expand its product offerings and enhance its platform. The company is focusing on developing new features tailored for emerging healthcare challenges. Additionally, there are initiatives for geographic expansion targeting other Latin American countries by the end of 2024, aiming to strengthen its market presence and technology adoption in new regions.